Dementia does not directly destroy hair follicles or trigger the kind of shedding you would see with, say, chemotherapy. But the relationship between dementia and hair loss is real, running through several indirect pathways that are easy to miss if you only look for a single cause-and-effect arrow. Shared autoimmune processes, behavioral symptoms of dementia itself, medications prescribed for cognitive decline, and overlapping hormonal shifts all create situations where someone with dementia ends up losing hair. The picture is more layered than a simple yes or no.
An Autoimmune Thread Connecting Hair Loss and Dementia
One of the most striking connections comes from research into alopecia areata, the autoimmune condition where the immune system attacks hair follicles and causes patchy baldness. A large nationwide cohort study found that people with alopecia areata were roughly three times more likely to develop dementia of any type compared to people without it, and more than four times as likely to develop Alzheimer’s disease specifically.1PubMed. Association of Alopecia Areata and the Risk of Dementia: A Nationwide Cohort Study That is a substantial increase in risk, even after adjusting for other health factors.
The direction of the link matters here. The study tracked people who already had alopecia areata and followed them forward in time to see who later developed dementia. So this is not evidence that dementia causes hair loss. It is evidence that the same kind of immune dysregulation behind autoimmune hair loss may also contribute to neurodegeneration down the road. Alopecia areata involves inflammatory cells clustering around active hair follicles and destroying them.2Journal of Investigative Dermatology. Substance P as an Immunomodulatory Neuropeptide in a Mouse Model for Autoimmune Hair Loss (Alopecia Areata) If that same inflammatory tendency extends to the brain, it could plausibly accelerate the damage seen in Alzheimer’s and other dementias. The research does not prove causation in either direction, but the shared autoimmune basis is hard to ignore.
For someone noticing hair loss and worrying about dementia, the takeaway is nuanced. Having alopecia areata does not mean you will get dementia. The absolute risk remains relatively low even with the elevated hazard ratio. But if you have an autoimmune hair-loss condition alongside other risk factors for cognitive decline, it is worth mentioning to your doctor as part of the broader picture.
When Dementia Itself Causes Hair Pulling
There is, however, one way dementia can cause visible hair loss quite directly: through a behavioral symptom called trichotillomania, or compulsive hair pulling. This is not the kind of trichotillomania typically seen in younger people with obsessive-compulsive tendencies. In dementia patients, it emerges as a repetitive, often uncontrollable behavior tied to the brain damage itself.
Case reports describe this vividly. One involved an 87-year-old man with vascular dementia who developed hair pulling as a form of perseveration, meaning his damaged brain got stuck in a repetitive loop it could not break out of.3PubMed Central. Trichotillomania in a dementia case Another case documented a woman who, eight years into her disease, began pulling her hair so severely and constantly that she eventually removed most of the hair on her scalp.4PubMed Central. Trichotillomania as a Manifestation of Dementia In frontotemporal dementia especially, compulsive hair pulling has been attributed to the loss of inhibitory control from the frontal lobes. When those brain regions degrade, behaviors that would normally be suppressed, including repetitive grooming actions, can emerge unchecked.5PubMed Central. Trichotillomania Ranging from “Ritual to Illness” and as a Rare Clinical Manifestation of Frontotemporal Dementia: Review of Literature and Case Report
If you are caring for someone with dementia and notice bald patches that seem to appear without an obvious medical explanation, hair pulling is worth considering, particularly if the person shows other repetitive or compulsive behaviors. It is not always dramatic or visible in real time. Some patients pull hair unconsciously, during periods of agitation, or when left alone. Recognizing it as a symptom of the dementia rather than a separate problem can change how caregivers and clinicians respond.
Medications Prescribed for Dementia Can Thin Hair
A less obvious but surprisingly common pathway from dementia to hair loss runs through the medicine cabinet. Many of the drugs used to manage the psychiatric symptoms that accompany dementia, such as agitation, depression, anxiety, and psychosis, have hair loss as a documented side effect. Mood stabilizers and antidepressants are frequent culprits. Among antipsychotics, haloperidol, olanzapine, and risperidone have all been associated with hair thinning, as have certain anti-anxiety medications like clonazepam and buspirone.6PubMed. Hair loss in psychopharmacology
The mechanism varies by drug class. Some medications shift more hair follicles into the resting phase of the growth cycle prematurely, leading to diffuse thinning a few months after starting treatment. Others may alter hormone levels or interfere with nutrient absorption in ways that affect hair health. The hair loss is usually not permanent and tends to reverse once the medication is stopped or switched, but for someone already dealing with the stresses of dementia, it can be distressing for both the patient and their family.
Caregivers often do not connect a new medication with hair changes that show up weeks or months later. If you notice increased shedding after a medication change, flag it with the prescribing doctor. There may be an alternative drug in the same class that is less likely to affect hair.
Do Hair Loss Treatments Affect Cognition?
The question also works in reverse: can treatments for hair loss affect the brain? This is most relevant for finasteride and dutasteride, two drugs commonly prescribed for male-pattern baldness and enlarged prostate. These drugs work by blocking an enzyme that converts testosterone into a more potent form, and that enzyme also plays a role in the brain’s production of neurosteroids, chemical messengers that influence mood and cognition.
A large cohort study looking at long-term use of these drugs found that when the data was followed over time, the initial statistical signal linking them to dementia faded, suggesting neither finasteride nor dutasteride meaningfully increases the risk of Alzheimer’s disease, vascular dementia, or suicide. Depression, however, remained a concern.7JAMA Network Open. Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide That is reassuring on the dementia front, but the cognitive picture is not entirely settled.
A separate analysis using national health survey data found a significant association between finasteride use and self-reported memory problems, with finasteride users having roughly six times the odds of reporting memory difficulties compared to non-users after adjusting for other factors.8PubMed Central. Association between finasteride with subjective memory deficits: a study from the NHANES and FAERS databases That is a striking number, but it comes with important caveats: self-reported memory complaints are not the same as clinically diagnosed cognitive decline, and the confidence interval was wide, meaning the true effect could be much smaller. Research into what some call “post-finasteride syndrome” has documented persistent cognitive complaints in some patients, alongside changes in neuroactive steroid levels in cerebrospinal fluid.9The Journal of Steroid Biochemistry and Molecular Biology. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients
If you are taking finasteride for hair loss and experiencing brain fog or memory concerns, that is worth discussing with your prescriber. Most people tolerate the drug without cognitive issues, but the subset who report problems should not have those complaints dismissed outright.
Hormonal Shifts That Affect Both Hair and Brain
Some conditions are capable of producing both hair loss and cognitive symptoms simultaneously, without one causing the other. Menopause is perhaps the most common example. The drop in estrogen that accompanies menopause affects hair follicles directly. Estrogen receptors in skin and hair follicles help regulate hair growth, and when estrogen levels fall, roughly a third of menopausal women experience noticeable hair thinning, particularly around the forehead and temples.10PubMed Central. Estrogen receptor β-Selective Phytoestrogenic (Phyto- β -SERM) Formulation Prevents Physical and Neurological Changes in a Preclinical Model of Human Menopause At the same time, declining estrogen is linked to cognitive changes and may accelerate neurodegeneration in women already predisposed to Alzheimer’s disease.
Thyroid disorders create a similar overlap. Hypothyroidism, where the thyroid gland underproduces its hormones, is well known for causing hair loss, fatigue, weight gain, and depression. In older adults, it can also impair cognitive function in ways that mimic or worsen dementia.11PubMed Central. Cognitive function in subclinical hypothyroidism in elderly The clinical presentation of hypothyroidism in elderly people is often different from what doctors expect in younger patients, which means it can go undiagnosed for years. An older person losing hair and showing signs of cognitive decline might be assumed to have age-related dementia when the real problem is a treatable thyroid deficiency.
This is one of the most practically important points in the whole topic. If you or someone you care for is experiencing both hair thinning and cognitive changes, ask for a thyroid panel. Subclinical hypothyroidism is common in older adults and is one of the reversible causes of dementia-like symptoms. Catching it can improve both the hair loss and the mental fog.
Hair as a Diagnostic Window Into Alzheimer’s
Researchers have explored a surprising use for hair in the context of dementia: as a diagnostic tool. Hair accumulates trace elements over time, and since it grows slowly and is not subject to the hour-to-hour fluctuations that affect blood levels, it may offer a more stable snapshot of a person’s long-term mineral status. A study comparing trace elements in the hair and blood of Alzheimer’s patients and healthy controls found significant imbalances in six elements, and suggested that hair analysis could be superior to blood analysis for detecting these changes because of the more permanent nature of hair’s mineral record.12PubMed. A comparison of hair and serum trace elements in patients with Alzheimer disease and healthy participants Earlier work examining 17 elements in the hair and nails of 180 Alzheimer’s patients and controls confirmed similar imbalances, identifying differences in elements like calcium, zinc, mercury, and potassium.13PubMed. Trace element imbalances in hair and nails of Alzheimer’s disease patients
This does not mean that a hair sample can diagnose Alzheimer’s today. The research is still exploratory, and the imbalances found are not specific enough to serve as a standalone test. But the idea that hair could supplement blood-based biomarkers is intriguing, especially for screening purposes in populations where repeated blood draws are impractical or distressing, as is often the case with dementia patients.
Separately, scientists have used hair follicle cells to study the body’s internal clocks. Hair follicles contain peripheral circadian clocks, and researchers have tested whether dementia disrupts these clocks at the cellular level. Data from hair follicle samples showed that the autonomous circadian oscillation in cells from dementia patients had no distinct abnormalities compared to healthy subjects.14Scientific Reports. A simple method using ex vivo culture of hair follicle tissue to investigate intrinsic circadian characteristics in humans In other words, whatever dementia does to sleep-wake cycles and daily rhythms at the whole-body level, it does not appear to break the clock machinery inside individual cells. Hair follicles, it turns out, are a surprisingly useful and non-invasive window into biology that has nothing to do with hair itself.
Aging, Stem Cells, and Why Both Problems Get Worse Together
At the most fundamental biological level, hair loss and cognitive decline both accelerate with age because they share some of the same cellular vulnerabilities. Hair follicle stem cells cycle between active and resting phases, and their long-term maintenance depends on metabolic signaling pathways that also govern cell health elsewhere in the body. Research into stem cell senescence has shown that a signaling pathway involving mTORC2 and Akt helps return hair follicle progenitor cells to a low-oxygen niche during the resting phase, restoring their ability to function in future growth cycles.15Stem Cells Translational Medicine. Metabolic regulation in the senescence process of stem cells When these metabolic processes falter with age, the stem cells lose their regenerative capacity, and hair growth slows or stops.
Similar metabolic and inflammatory shifts contribute to brain aging. Chronic low-grade inflammation, impaired nutrient sensing, and accumulating cellular damage are hallmarks of both hair follicle exhaustion and neurodegenerative disease. Neither condition causes the other, but they are both downstream of the same aging machinery. That is why they so often appear in the same person at the same time, creating the impression of a causal link where the real explanation is a shared upstream driver.
This framing matters because it changes what you can reasonably do about it. You cannot prevent age-related stem cell decline entirely, but the modifiable risk factors for dementia, including physical activity, cardiovascular health, blood sugar control, and managing chronic inflammation, overlap heavily with the factors that support healthy hair growth. Keeping your vascular system in good shape, for instance, supports blood flow to both the brain and the scalp. Managing thyroid function and hormonal balance, as discussed earlier, protects both. The two problems are not one disease, but they share enough biology that addressing the common ground may help with both.